- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
CT proves clinical worth in bowel obstruction cases
Two and a half years worth of data suggest that CT is the most accurate, cost-effective imaging modality for diagnosing the causes of large bowel obstruction, according to investigators in the U.K.
Two and a half years worth of data suggest that CT is the most accurate, cost-effective imaging modality for diagnosing the causes of large bowel obstruction, according to investigators in the U.K.
Principal researcher Dr. Sathi Sukumar, a consultant radiologist at the University Hospital of South Manchester, and colleagues retrospectively reviewed 2400 CT reports on inpatient cases of suspected large bowel obstruction, large bowel dilatation, or pseudo-obstruction spanning 30 months of clinical practice. They identified 42 on whom clinical, endoscopic, and surgical follow-up data were available. The investigators found that CT was highly sensitive and specific in identifying the causes of dilated large bowel loops in these patients. They released preliminary findings at the 2008 American Roentgen Ray Society meeting.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
